In addition, we recently demonstrated that AQP4 polarisation and glymphatic function were reduced in the brain of a transgenic mouse model of tauopathy, and that acute pharmacological blockade of AQP4 resulted in disrupted tau clearance from the brain [16]. The gene discussed is MAPT; the disease is tauopathy.